← Leaderboards
Steve N Caritis
University Of Pittsburgh At Pittsburgh
$23,921,687
Attributed
$24,282,461
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$27,949,536 · 13
By mechanism
U10$16,840,570 · 2
U54$6,397,197 · 3
R01$3,411,405 · 1
T32$721,548 · 1
M01$578,816 · 6
Top collaborators
- Raman Venkataramanan5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Raman Venkataramanan$1,853,498
- Hyagriv N Simhan$12,877,256
- Jordan F Karp$3,173,062
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyClinical ResearchWomanPregnant WomenDosePharmacologyPharmaceutical PreparationsFetalBaseSiteUniversitiesResourcesPharmacodynamicsLiquid SubstanceDrug KineticsDiscipline Of ObstetricsInfantProtocols DocumentationResearch ActivityResearch PersonnelFacultyFemaleHuman Therapy EvaluationBiological
Grant awards (72)
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy$643,449
R01 · FY2022 · HD · contact PI
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy$667,106
R01 · FY2021 · HD · contact PI
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy$690,940
R01 · FY2020 · HD · contact PI
Optimization of Drug Dosing in Pregnant Women through Research and Education$767,882
U54 · FY2019 · HD · contact PI
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy$693,229
R01 · FY2019 · HD · contact PI
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics$318,711
U54 · FY2019 · HD · contact PI
OPRC Administrative Core$248,964
U54 · FY2019 · HD · contact PI
Optimization of Drug Dosing in Pregnant Women through Research and Education$775,636
U54 · FY2018 · HD · contact PI
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy$716,681
R01 · FY2018 · HD · contact PI
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics$368,418
U54 · FY2018 · HD · contact PI
OPRC Administrative Core$290,919
U54 · FY2018 · HD · contact PI
Optimization of Drug Dosing in Pregnant Women through Research and Education$781,288
U54 · FY2017 · HD · contact PI
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics$334,609
U54 · FY2017 · HD · contact PI
OPRC Administrative Core$248,326
U54 · FY2017 · HD · contact PI
Optimization of Drug Dosing in Pregnant Women through Research and Education$779,773
U54 · FY2016 · HD · contact PI
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics$251,925
U54 · FY2016 · HD · contact PI
OPRC Administrative Core$247,343
U54 · FY2016 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$194,983
T32 · FY2016 · HD · contact PI
Optimization of Drug Dosing in Pregnant Women through Research and Education$562,496
U54 · FY2015 · HD · contact PI
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics$238,554
U54 · FY2015 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$203,153
T32 · FY2015 · HD · contact PI
OPRC Administrative Core$182,353
U54 · FY2015 · HD · contact PI
Multicenter Network of Maternal Fetal Medicine Units$67,485
U10 · FY2015 · HD · contact PI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response$937,295
U10 · FY2014 · HD · contact PI
Multicenter Network of Maternal Fetal Medicine Units$65,595
U10 · FY2014 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$59,750
T32 · FY2014 · HD · contact PI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response$906,834
U10 · FY2013 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$133,438
T32 · FY2013 · HD · contact PI
Multicenter Network of Maternal Fetal Medicine Units$64,044
U10 · FY2013 · HD · contact PI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response$801,825
U10 · FY2012 · HD · contact PI
Training in Basic and Clinical Pharmacology in Pregnancy$130,224
T32 · FY2012 · HD · contact PI
Multicenter Network of Maternal Fetal Medicine Units$71,192
U10 · FY2012 · HD · contact PI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response$695,353
U10 · FY2011 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$80,006
U10 · FY2011 · HD · contact PI
Multicenter Network of Maternal Fetal Medicine Units$79,500
U10 · FY2011 · HD · contact PI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response$1,027,538
U10 · FY2010 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$247,442
U10 · FY2010 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$563,786
U10 · FY2009 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$441,307
U10 · FY2009 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$285,225
U10 · FY2009 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$570,947
U10 · FY2008 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$550,971
U10 · FY2008 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$135,000
U10 · FY2008 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$582,600
U10 · FY2007 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$473,556
U10 · FY2007 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$956,059
U10 · FY2006 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$600,000
U10 · FY2006 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$150,000
U10 · FY2006 · HD · contact PI
Pregnancy and Drug Metabolizing Enzymes and Transporters$1,761,994
U10 · FY2005 · HD
MULTICENTER NETWORK OF MATERNAL-FETAL MEDICINE UNITS$471,837
U10 · FY2005 · HD
COMBINED ANTIOXIDANT AND PREECLAMPSIA PREDICTION STUDIES (CAPPS)$453,682
M01 · FY2005 · RR
17 ALPHA-HYDROXYPROGESTERONE CAPROATE FOR PREVENTION OF PRETERM BIRTH$30,646
M01 · FY2005 · RR
A RANDOMIZED CLINICAL TRIAL OF TREATMENT FOR MILD GESTATIONAL DIABETES$12,324
M01 · FY2005 · RR
MULTICENTER NETWORK OF MATERNAL-FETAL MEDICINE UNITS$1,038,290
U10 · FY2004 · HD
Pregnancy and Drug Metabolizing Enzymes and Transporters$637,630
U10 · FY2004 · HD
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)$54,691
M01 · FY2004 · RR
Drug Metabolism in Pregnancy$20,096
M01 · FY2004 · RR
Clinical Trial of Treatment for Mild Gestational DM$7,377
M01 · FY2004 · RR
MULTICENTER NETWORK OF MATERNAL-FETAL MEDICINE UNITS$493,338
U10 · FY2003 · HD
COOPERATIVE MULTICENTER MATERNAL-FETAL MEDICINE UNITS N*$3,009
U10 · FY2003 · HD
COOPERATIVE MULTICENTER MATERNAL-FETAL MEDICINE UNITS N*$870,131
U10 · FY2002 · HD
MULTICENTER NETWORK OF MATERNAL FETAL MEDICINE UNITS$2,479
U10 · FY2002 · HD
METRONIDAZOLE PLUS ERYTHROMYCIN TO PREVENT PRETERM BIRTH IN WOMEN$0
M01 · FY2002 · RR
17ALPHA HYDROXYPROGESTERONE FOR PRETERM BIRTH PREVENTION$0
M01 · FY2002 · RR
17ALPHA HYDROXYPROGESTERONE FOR PRETERM BIRTH PREVENTION$0
M01 · FY2002 · RR
METRONIDAZOLE PLUS ERYTHROMYCIN TO PREVENT PRETERM BIRTH IN WOMEN$0
M01 · FY2002 · RR
MULTICENTER NETWORK OF MATERNAL FETAL MEDICINE UNITS$614,777
U10 · FY2001 · HD
METRONIDAZOLE PLUS ERYTHROMYCIN TO PREVENT PRETERM BIRTH IN WOMEN$0
M01 · FY2001 · RR
17ALPHA HYDROXYPROGESTERONE FOR PRETERM BIRTH PREVENTION$0
M01 · FY2001 · RR
MULTICENTER NETWORK OF MATERNAL FETAL MEDICINE UNITS$593,525
U10 · FY2000 · HD
17ALPHA HYDROXYPROGESTERONE FOR PRETERM BIRTH PREVENTION$0
M01 · FY2000 · RR
METRONIDAZOLE PLUS ERYTHROMYCIN TO PREVENT PRETERM BIRTH IN WOMEN$0
M01 · FY2000 · RR